Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis

Abstract Background Chitinase-3 like-protein-1 (CHI3L1) is a member of the mammalian chitinase-like proteins and elevated serum CHI3L1 level has been proved to be associated with poor prognosis in hepatocellular carcinoma (HCC). This study aimed to investigate the relationship between serum CHI3L1 l...

Full description

Bibliographic Details
Published in:	BMC Cancer
Main Authors:	Chiyu He, Zhihang Hu, Zuyuan Lin, Hao Chen, Chenghao Cao, Jinyan Chen, Xudong Yang, Huigang Li, Wei Shen, Xuyong Wei, Li Zhuang, Shusen Zheng, Xiao Xu, Di Lu
Format:	Article
Language:	English
Published:	BMC 2024-08-01
Subjects:	Myosteatosis CHI3L1 Hepatocellular carcinoma Liver transplantation Computer tomography
Online Access:	https://doi.org/10.1186/s12885-024-12808-3

Similar Items

Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma
by: Pei-Jui Luo, et al.
Published: (2025-09-01)

Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer
by: Di Lu, et al.
Published: (2022-12-01)

Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors
by: Mengchen Liu, et al.
Published: (2024-04-01)

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01)

Clinical impact of myosteatosis measured by magnetic resonance imaging on long-term outcomes of hepatocellular carcinoma after radical hepatectomy
by: Kozo Yoshikawa, et al.
Published: (2023-09-01)

Comment on ‘Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma’ by Lu et al.
by: Aikaterini Kamiliou, et al.
Published: (2024-12-01)

The effects of myosteatosis on skeletal muscle function in older adults
by: Kathleen Dondero, et al.
Published: (2024-05-01)

Association between atherogenic dyslipidemia and muscle quality defined by myosteatosis
by: Hwi Seung Kim, et al.
Published: (2024-08-01)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
by: Min-Kyu Kang, et al.
Published: (2022-09-01)

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis
by: Chan Mi Lee, et al.
Published: (2020-10-01)

The Impact of Sarcopenia, Myosteatosis, and Visceral Adiposity on Renal Transplantation Outcomes
by: Esin Olcucuoglu, et al.
Published: (2025-09-01)

Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis
by: Ninghui Zhao, et al.
Published: (2025-02-01)

Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
by: Byeong Jin Kang, et al.
Published: (2024-11-01)

Association between myosteatosis or sarcopenia based on abdominal CT and hypertension in systemic lupus erythematosus patients
by: Bowen Wang, et al.
Published: (2025-03-01)

Varying clinical relevance of sarcopenia and myosteatosis according to age among patients with postoperative colorectal cancer
by: Hye Jung Cho, et al.
Published: (2024-07-01)

Combined impact of myosteatosis and liver steatosis on prognosis in stage I–III colorectal cancer patients
by: Dong Hee Lee, et al.
Published: (2023-12-01)

The Role of Frailty and Myosteatosis in Predicting All-Cause Mortality in Older Adults with Cancer
by: Efthymios Papadopoulos, et al.
Published: (2024-12-01)

Metabolic Markers Demonstrate the Heterogeneity of Myosteatosis in Community-Dwelling Older Black Men from the Health ABC Study
by: Samaneh Farsijani, et al.
Published: (2021-04-01)

Myosteatosis in a systemic inflammation‐dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer
by: Camila T. B. Gabiatti, et al.
Published: (2019-11-01)

THE FEATURES OF PREOPERATIVE MYOPENIA, MYOSTEATOSIS, AND PHYSICAL FUNCTION IN JAPANESE PATIENTS WITH GASTROINTESTINAL CANCER: A CROSS-SECTIONAL STUDY
by: Noriatsu Tatematsu, et al.
Published: (2023-10-01)

Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma
by: Di Lu, et al.
Published: (2024-10-01)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
by: Maxime Nachit, et al.
Published: (2021-02-01)

SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer
by: Daniel L. Hess, et al.
Published: (2023-11-01)

Myosteatosis as a Prognostic Marker for Postoperative Mortality in Adult Patients Undergoing Surgery in General—A Systematic Review
by: Onno Emanuel den Os, et al.
Published: (2023-11-01)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
by: Qi Chen, et al.
Published: (2022-04-01)

RORα–GABP–TFAM axis alleviates myosteatosis with fatty atrophy through reinforcement of mitochondrial capacity
by: Hyeon‐Ji Kim, et al.
Published: (2024-04-01)

What is the functional impact of sarcopenia and myosteatosis three months after discharge to an intensive care population? A monocentric observational study
by: Margot Dressaire, et al.
Published: (2024-10-01)

Preoperative myosteatosis and perioperative serum chloride levels predict 180 day major complications after radical cystectomy
by: Wassapol Sornthai, et al.
Published: (2025-01-01)

Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures
by: Sammy Badr, et al.
Published: (2023-06-01)

Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: an updated systematic review and meta-analysis
by: Yu-Yao Chang, et al.
Published: (2024-06-01)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
by: Malcolm A. West, et al.
Published: (2019-08-01)

CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery
by: Zhongze Du, et al.
Published: (2024-08-01)

Impact of myosteatosis on prognosis in multiple myeloma patients: A subgroup analysis of 182 cases and development of a nomogram
by: Jun-Peng Liu, et al.
Published: (2025-04-01)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
by: Chen Fu, et al.
Published: (2023-03-01)

The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation
by: Zoltan Czigany, et al.
Published: (2021-04-01)

Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study
by: Antoine Morel, et al.
Published: (2022-02-01)

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery
by: Yan Liu, et al.
Published: (2024-04-01)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
by: Hong-Kyu Kim, et al.
Published: (2023-10-01)

Thr92Ala-DIO2 heterozygosity is associated with skeletal muscle mass and myosteatosis in patients with COVID-19
by: Fabyan Esberard de Lima Beltrão, et al.
Published: (2024-08-01)